Description
Useful Information
DOSAGE AND ADMINISTRATION
The dosage of oxibendazole is 10 mg/kg (2.2 lb) of body weight (15 mg/kg for strongyloides). Each mark on the syringe delivers Anthelcide EQ to treat 100 lb (67 lb for strongyloides). Horses maintained on premises where reinfection is likely to occur should be retreated in 6–8 weeks.
Anthelcide EQ is compatible with carbon disulfide, which can be used concurrently for bot control (Gasterophilus spp.) when administered by a veterinarian. Routine carbon disulfide cautions must be observed.
USE OF SYRINGE
Determine the weight of the horse and dial the correct setting on the plunger, having the side of the wheel nearest the barrel on the desired mark. Remove the cap from the syringe. Insert the tip of the syringe into the side of the animal's mouth between the incisor and molar teeth and press the plunger down as far as it will go, depositing the paste on the back of the tongue.
WARNINGS
Do not use in horses intended for human consumption.
Not for use in humans. Keep this and all drugs out of reach of children.
HUMAN WARNINGS
Not for use in humans. Keep this and all drugs out of the reach of children. Refrain from eating or smoking when handling. Wash hands after use. Avoid contact with eyes. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse reactions in users, to obtain more information, or to obtain a MSDS, contact Bimeda Inc. at 1-888-524-6332.
PRECAUTIONS
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
HOW SUPPLIED
Anthelcide EQ Paste is supplied in 12 0.85-oz (24-g) syringes.
Store at controlled room temperature 15°–30°C (59°–86°F).
NADA #121-042, Approved by FDA
ANTHELCIDE®EQ (oxibendazole)
Equine Wormer Paste
For use in horses only
Net Weight: 0.85 oz (24 g)
PRINCIPAL DISPLAY PANEL - 24 g Syringe Label
The dosage of oxibendazole is 10 mg/kg (2.2 lb) of body weight (15 mg/kg for strongyloides). Each mark on the syringe delivers Anthelcide EQ to treat 100 lb (67 lb for strongyloides). Horses maintained on premises where reinfection is likely to occur should be retreated in 6–8 weeks.
Dosage Table
|
Anthelcide EQ is compatible with carbon disulfide, which can be used concurrently for bot control (Gasterophilus spp.) when administered by a veterinarian. Routine carbon disulfide cautions must be observed.
USE OF SYRINGE
Determine the weight of the horse and dial the correct setting on the plunger, having the side of the wheel nearest the barrel on the desired mark. Remove the cap from the syringe. Insert the tip of the syringe into the side of the animal's mouth between the incisor and molar teeth and press the plunger down as far as it will go, depositing the paste on the back of the tongue.
WARNINGS
Do not use in horses intended for human consumption.
Not for use in humans. Keep this and all drugs out of reach of children.
HUMAN WARNINGS
Not for use in humans. Keep this and all drugs out of the reach of children. Refrain from eating or smoking when handling. Wash hands after use. Avoid contact with eyes. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information. To report adverse reactions in users, to obtain more information, or to obtain a MSDS, contact Bimeda Inc. at 1-888-524-6332.
PRECAUTIONS
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.
HOW SUPPLIED
Anthelcide EQ Paste is supplied in 12 0.85-oz (24-g) syringes.
Store at controlled room temperature 15°–30°C (59°–86°F).
NADA #121-042, Approved by FDA
ANTHELCIDE®EQ (oxibendazole)
Equine Wormer Paste
For use in horses only
Net Weight: 0.85 oz (24 g)
PRINCIPAL DISPLAY PANEL - 24 g Syringe Label